Optimind Pharma Corp.
OMND
CNSX
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 73.20K | 67.00K | 107.10K | 21.10K | 23.60K |
| Total Receivables | 43.10K | 58.40K | 37.70K | 117.50K | 113.30K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 116.30K | 125.40K | 144.80K | 138.70K | 136.90K |
|
|
|||||
| Total Current Assets | 116.30K | 125.40K | 144.80K | 138.70K | 136.90K |
| Net Property, Plant & Equipment | -- | -- | -- | 0.00 | 0.00 |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | 273.50K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | 142.30K |
| Total Assets | 152.00K | 162.40K | 181.40K | 175.50K | 589.60K |
|
|
|||||
| Total Accounts Payable | 96.60K | 98.30K | 255.40K | 178.00K | 77.90K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 89.70K | 93.10K | 92.10K | 92.60K | 420.80K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 186.30K | 191.40K | 347.40K | 270.60K | 498.70K |
|
|
|||||
| Total Current Liabilities | 186.30K | 191.40K | 347.40K | 270.60K | 498.70K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 89.70K | 93.10K | 92.10K | 92.60K | 420.80K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 6.50K |
| Total Liabilities | 186.30K | 191.40K | 347.40K | 270.60K | 505.20K |
|
|
|||||
| Common Stock & APIC | 3.43M | 3.56M | 3.32M | 3.34M | 3.00M |
| Retained Earnings | -3.58M | -3.71M | -3.61M | -3.55M | -3.03M |
| Treasury Stock & Other | 115.90K | 120.30K | 119.00K | 119.70K | 119.70K |
| Total Common Equity | -34.40K | -29.00K | -166.00K | -95.10K | 84.40K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -34.40K | -29.00K | -166.00K | -95.10K | 84.40K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -34.40K | -29.00K | -166.00K | -95.10K | 84.40K |
|
|
|||||
